Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management.

@article{Grani2018FollicularTC,
  title={Follicular thyroid cancer and H{\"u}rthle cell carcinoma: challenges in diagnosis, treatment, and clinical management.},
  author={Giorgio Grani and Livia Lamartina and Cosimo Durante and Sebastiano Filetti and David S Cooper},
  journal={The lancet. Diabetes \& endocrinology},
  year={2018},
  volume={6 6},
  pages={
          500-514
        }
}
View on PubMed
doi.org
90 Citations
Highly Influential Citations
6
Background Citations
26
Methods Citations
2
Results Citations
5

Tables from this paper

90 Citations

Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literature
TLDR
This case exemplifies that thorough aftercare and aggressive treatment enables long-term survival even in recurrent Hurthle cell thyroid carcinoma displaying unusual multisite metastases, and demonstrates the importance of consistent aftercare.
Advancements in the treatment of differentiated thyroid cancer
  • L. Stewart, J. Kuo
  • Medicine, Biology
    Therapeutic advances in endocrinology and metabolism
  • 2021
TLDR
Although surgery and radioiodine ablation remain the mainstay of DTC therapy, the role of active surveillance is being explored and the most recent American Thyroid Association guidelines offer flexibility between lobectomy and total thyroidectomy for thyroid nodules between 1’cm and 4 cm in the absence of extrathyroidal extension or nodal disease.
Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
TLDR
The study suggests that recurrence is more often seen in OFTC patients, who have a poorer prognosis for disease-free survival than FTC patients after initial RIT.
Multimodal imaging of thyroid cancer
TLDR
The mainstay of diagnosing thyroid cancer is thyroid ultrasound with ultrasound-guided FNB, and contrast-enhanced computed tomography and PET with [ 18F]-fluorodeoxyglucose (FDG) and MRI are reserved for advanced and/or recurrent cases of differentiated thyroid cancer and anaplastic thyroid cancer, while [18F]FDOPA and [68Ga]DOTATOC are the preferred tracers for medullary thyroid cancer.
Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
TLDR
Current knowledge of Hürthle cell carcinoma, including clinical, pathological, and molecular features, with the aim of improving clinical management, is reviewed.
Follicular Thyroid Cancer
Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse
TLDR
In conclusion, surgery for cervical radioiodine refractory FTC relapse is often performed in metastatic setting, and cure is rare, although metastases can appearRadioiodine avid.
Recent advances in managing differentiated thyroid cancer
TLDR
There has been a notable shift toward more conservative management of low- and intermediate-risk patients, characterized by less extensive surgery, more selective use of radioisotopes, and less intensive follow-up.
Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
TLDR
The results of the present study suggested that the prognosis of WIFTC was the worst among patients with FTC and distant metastasis, and that total thyroidectomy surgery and radioactive iodine treatment are essential.
Recent advances in managing differentiated thyroid cancer [version 1; referees: 2 approved]
TLDR
There has been a notable shift toward more conservative management of low- and intermediate-risk patients, characterized by less extensive surgery, more selective use of radioisotopes, and less intensive follow-up.
...
...

References

SHOWING 1-10 OF 159 REFERENCES
Follicular thyroid carcinoma
TLDR
The differential diagnosis between follicular carcinomas and three tumor types—follicular adenoma, follicular variant of papillary carcinoma and poorly differentiated carcinoma—as well as the problems raised by the newly described categories of follicular tumors are addressed.
The History of the Follicular Variant of Papillary Thyroid Carcinoma.
TLDR
The encapsulated/well-demarcated, noninvasive form of FVPTC was renamed as non invasive follicular thyroid neoplasm with papillary-like nuclear features, enabling clinicians to avoid aggressive therapy.
Differentiated thyroid carcinoma: defining new paradigms for postoperative management.
TLDR
This review examines some of the key issues in this area, including the assessment of risks for disease recurrence and thyroid cancer-related death, the indications for postoperative ablation of the thyroid remnant with radioactive iodine and TSH-suppressive doses of levothyroxine, the pros, cons, and rationales for the use of various follow-up tools.
A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma
TLDR
Trends in rates of FTC versus FV-PTC in the U.S. are described and a risk assessment tool is developed to aid clinicians in predicting final diagnosis and shaping treatment plans to aid patient and clinician discussions and decision making.
Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?
TLDR
The aims of this study were to review FTC histologically at the authors' tertiary care institution and to evaluate long-term survival and recurrence.
Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland
TLDR
The current study attempted to identify predictors of recurrence in EHC, and focused on the encapsulated Hurthle cell carcinoma (EHC).
Well-Differentiated Thyroid Cancer: The Philippine General Hospital Experience
TLDR
Overall, PTC among Filipino was associated with a more aggressive and recurrent behavior, and FTC among Filipinos appeared to behave similarly with other racial groups.
Management of thyroid follicular proliferation: an ultrasound-based malignancy score to opt for surgical or conservative treatment.
Can Minimally Invasive Follicular Thyroid Cancer be Approached as a Benign Lesion?
TLDR
Thyroid lobectomy alone may be considered adequate treatment in these patients with MIFC and is associated with survival comparable to that of the normative US general population.
Thyroid follicular carcinoma: sonographic features of 50 cases.
TLDR
No significant difference in the prevalence of refractive shadowing, echotexture, visible invasion, lymph node enlargement, adjacent nonfollicular suspicious lesions, vascularity subtype, and calcifications was observed between the two groups, but Hypoechoic appearance was more frequently associated with follicular thyroid cancer than with benign adenoma.
...
...